June 2020 ACCP Virtual Journal Club Webinar: Evaluation of the Effect of 5 QT-Positive Drugs on the JTpeak Interval – An Analysis of ECGs From the IQ-CSRC Study
Date: Wednesday, June 17, 2020
Time: 2:00 – 3:00 PM ET
Speaker: Borje Darpo, MD, PhD, Chief Scientific Officer, Cardiac Safety, ERT
Listen in as ERT’s Dr. Borje Darpo explains how to conduct a comprehensive assessment of proarrhythmic risk for drugs in development. He’ll focus on the JTpeak interval, a novel clinical biomarker that has been suggested to replace or complement the QT interval as a proarrhythmic risk assessment tool.
Attendees that complete this course will gain clinical pearls and a comprehensive understanding and insight into proarrhythmic risk of drugs and use of a novel clinical marker, JTpeak interval and its electrophysiological meaning.
DR. BORJE DARPO
Chief Scientific Officer of Cardiac Safety